Zenabis Announces Overnight Marketed Public Offering of Units for Proceeds of Approximately 6 Million

 – Zenabis Global Inc. (TSX: ZENA) (“Zenabis” or the “Company“) is pleased to announce that it is commencing a “best efforts” overnight marketed offering of units (“Units“) of the Company (the “Offering“) for gross proceeds of approximately $6,000,000 with ATB Capital Markets Inc., as lead agent on behalf of a syndicate of agents to be formed (collectively, the “Agents“).Continue reading “Zenabis Announces Overnight Marketed Public Offering of Units for Proceeds of Approximately 6 Million”

Acreage Announces Amendment of Warrant Terms

— Acreage Holdings, Inc. (“Acreage” or “Company”) (CSE: ACRG.U) (OTCQX: ACRGF) (FSE: 0VZ) today announces its intention to amend the term and exercise price of the 6,085,192 Class A subordinate voting share purchase warrants (the “Warrants”) issued as part of the Company’s private placement which closed on February 10, 2020. Under the current terms, eachContinue reading “Acreage Announces Amendment of Warrant Terms”

Emerald Announces $2.1 Million Prospectus Sale

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, May 21, 2020 (GLOBE NEWSWIRE) — Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV: EMH; OTCQX: EMHTF), has entered into a binding term sheet with a single Canadian institutional accredited investor (the “Investor”) under which the Investor has agreed, subjectContinue reading “Emerald Announces $2.1 Million Prospectus Sale”